Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
Stopped Unble to complete all arms of the planned study due to Covid stoppage and difficulty with recruiting and getting enrolled participants to return post Covid.
Conditions
- Polycystic Ovary Syndrome
- Hypertension
Interventions
- DRUG: GnRH antagonist
- DRUG: GnRH antagonist + MethylTESTOSTERone 5 MG
Sponsor
Yale University
Collaborators